Sominone Improves Memory Impairments and Increases Axonal Density in Alzheimer's Disease Model Mice, 5XFAD

REFERENCES

• Braak, H., Rüb, U., Schultz, C., & Del Tredici, K. (2006). Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases. Journal of Alzheimers Disease, 9(3 Suppl), 35–44.
   PubMedGoogle Scholar
• Consales, C., Volpicelli, F., Greco, D., Leone, L., Colucci-D'Amato, L., Perrone-Capano, C., (2007). GDNF signaling in embryonic midbrain neurons in vitro. Brain Research, 1159, 28–39.
   PubMedGoogle Scholar
• Dickson, T. C., & Vickers, J. C. (2001). The morphological phenotype of β-amyloid plaques and associated neuritic changes in Alzheimer's disease. Neuroscience, 105, 99–107.
   PubMed Web of Science ®Google Scholar
• Eriksen, J. L., & Janus, C. G. (2007). Plaques, tangles, and memory loss in mouse models of neurodegeneration. Behavioral Genetics, 7, 79–100.
   Google Scholar
• Grace, E. A., Rabiner, C. A., & Busciglio, J. (2002). Characterization of neuronal dystrophy induced by fibrillar amyloid beta: Implications for Alzheimer's disease. Neuroscience, 114, 265–273.
   PubMed Web of Science ®Google Scholar
• Henry, D. B., May, P. C., Dean, R. A., & Siemers, E. R. (2009). Development of semagacestat (LY450139), a functional gamma-secretase inhibitor, for the treatment of Alzheimer's disease. Expert Opinion of Pharmacotherapy, 10, 1657–1664.
   PubMedGoogle Scholar
• Heredia, L., Helguera, P., de Olmos, S., Kedikian, G., Solá Vigo, F., LaFerla, F. (2006). Phosphorylation of actin-depolymerizing factor/cofilin by LIM-kinase mediates amyloid beta-induced degeneration: A potential mechanism of neuronal dystrophy in Alzheimer's disease. Journal of Neuroscience, 26, 6533–6542.
   PubMedGoogle Scholar
• Hu, X., Shi, Q., Zhou, X., He, W., Yi, H., Yin, X., (2007). Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities. EMBO Journal, 26, 2755–2767.
   PubMedGoogle Scholar
• Jawhar, S., Trawicka, A., Jenneckens, C., Bayer, T. A., & Wirths, O. (2010). Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer's disease. Neurobiology of Aging, Epub ahead of print.
   Google Scholar
• Knowles, R.B., Wyart, C., Buldyrev, S.V., Cruz, L., Urbanc, B., Hasselmo, M.E., et al. (1999). Plaque-induced neurite abnormalities: Implications for disruption of neural networks in Alzheimer's disease. Proceedings of the National Academy of Sciences USA, 96, 5274–5279.
   Google Scholar
• Kuboyama, T., Tohda, C., & Komatsu, K. (2005). Neuritic regeneration and synaptic reconstruction induced by withanolide A. British Journal of Pharmacology, 144, 961–971.
   PubMed Web of Science ®Google Scholar
• Kuboyama, T., Tohda, C., & Komatsu, K. (2006). Withanoside IV and its active metabolite, sominone, attenuate Aβ (25–35)-induced neurodegeneration. European Journal of Neuroscience, 23, 1417–1426.
   PubMedGoogle Scholar
• Matsuya, Y., Yamakawa, Y., Tohda, C., Teshigawara, K., Yamada, M., & Nemoto, H. (2009). Synthesis of sominone and its derivatives based on an RCM strategy: Discovery of a novel anti-Alzheimer's disease medicine candidate “denosomin”. Organic Letters, 11, 3970–3973.
   PubMedGoogle Scholar
• Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J. (2006). Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: Potential factors in amyloid plaque formation. Journal of Neuroscience, 26, 10129–10140.
   PubMed Web of Science ®Google Scholar
• Ohno, M., Chang, L., Tseng, W., Oakley, H., Citron, M., Klein, W. L., (2006). Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1. European Journal of Neuroscience, 23, 251–260.
   PubMed Web of Science ®Google Scholar
• Ohno, M. (2009). Failures to reconsolidate memory in a mouse model of Alzheimer's disease. Neurobiology of Learning and Memory, 92, 455–459.
   Google Scholar
• Ohno, M., Cole, S. L., Yasvoina, M., Zhao, J., Citron, M., Berry, R., (2007). BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice. Neurobiology of Disease, 26, 134–145.
   PubMed Web of Science ®Google Scholar
• Salloway, S., Sperling, R., Gilman, S., Fox, N.C., Blennow, K., Raskind, M. (2009). A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology, 73, 2061–2070.
   PubMed Web of Science ®Google Scholar
• Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R. (1991). Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Annals of Neurology, 30, 572– 580.
   PubMed Web of Science ®Google Scholar
• Tohda, C., & Joyashiki, E. (2009). Sominone enhances neurite outgrowth and spatial memory mediated by the neurotrophic factor receptor, RET. British Journal of Pharmacology, 157, 1427–1440.
   PubMedGoogle Scholar
• Tohda, C., Kuboyama, T., & Komatsu, K. (2005). Search for natural products related to regeneration of the neuronal network. Neurosignals, 14, 34–45.
   PubMed Web of Science ®Google Scholar
• Tohda, C., Matsumoto, N., Zou, K., Meselhy, M.R., & Komatsu, K. (2004). Aβ(25–35)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1, A metabolite of protopanaxadiol-type saponins. Neuropsychopharmacology, 29, 860–868.
   PubMedGoogle Scholar
• Tohda, C., Tamura, T., & Komatsu, K. (2003). Repair of amyloid β(25–35)-induced memory impairment and synaptic loss by a Kampo formula, Zokumei-to. Brain Research, 990, 141–147.
   PubMed Web of Science ®Google Scholar
• Tsai, J., Grutzendler, J., Duff, K., & Gan, W.B. (2004). Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nature Neuroscience, 7, 1181–1183.
   PubMed Web of Science ®Google Scholar
• Wu, H. Y., Hudry, E., Hashimoto, T., Kuchibhotla, K., Rozkalne, A., Fan, Z. (2010). Amyloid β induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation. Journal of Neuroscience, 30, 2636–2649.
   PubMed Web of Science ®Google Scholar